ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Long-term administration of salvianolic acid A promotes endogenous neurogenesis in ischemic stroke rats through activating Wnt3a/GSK3β/β-catenin signaling pathway

Zhang, Sen; Kong, De-Wen; Ma, Guo-Dong; Liu, Cheng-di; Yang, Yu-Jiao; Liu, Shan; Jiang, Nan; Pan, Zi-Rong; Zhang, Wen; Kong, Ling-Lei*; Du, Guan-Hua*广东药学院; 中国医学科学院; 中国医学科学院北京协和医院
Acta Pharmacologica Sinica2022-9DOI: 10.1038/s41401-021-00844-9
9被引8阅读
引用收藏
分享

摘要

Stroke is the major cause of death and disability worldwide. Most stroke patients who survive in the acute phase of ischemia display various extents of neurological deficits. In order to improve the prognosis of ischemic stroke, promoting endogenous neurogenesis has attracted great attention. Salvianolic acid A (SAA) has shown neuroprotective effects against ischemic diseases. In the present study, we investigated the neurogenesis effects of SAA in ischemic stroke rats, and explored the underlying mechanisms. An autologous thrombus stroke model was established by electrocoagulation. The rats were administered SAA (10 mg/kg, ig) or a positive drug edaravone (5 mg/kg, iv) once a day for 14 days. We showed that SAA administration significantly decreased infarction volume and vascular embolism, and ameliorated pathological injury in the hippocampus and striatum as well as the neurological deficits as compared with the model rats. Furthermore, we found that SAA administration significantly promoted neural stem/progenitor cells (NSPCs) proliferation, migration and differentiation into neurons, enhanced axonal regeneration and diminished neuronal apoptosis around the ipsilateral subventricular zone (SVZ), resulting in restored neural density and reconstructed neural circuits in the ischemic striatum. Moreover, we revealed that SAA-induced neurogenesis was associated to activating Wnt3a/GSK3 beta/beta-catenin signaling pathway and downstream target genes in the hippocampus and striatum. Edaravone exerted equivalent inhibition on neuronal apoptosis in the SVZ, as SAA, but edaravone-induced neurogenesis was weaker than that of SAA. Taken together, our results demonstrate that long-term administration of SAA improves neurological function through enhancing endogenous neurogenesis and inhibiting neuronal apoptosis in ischemic stroke rats via activating Wnt3a/GSK3 beta/beta-catenin signaling pathway. SAA may be a potential therapeutic drug to promote neurogenesis after stroke.

学科与关键词

关键词
ischemic strokesalvianolic acid AneurogenesisWnt3a/GSK3 beta/beta-catenin signalinghippocampusstriatum
相关
加载中…
  • Salvianolic acid A relieves cognitive disorder after chronic cerebral ischemia: Involvement of Drd2/Cryab/NF-κB pathway
    Yang, Yujiao; Song, Junke*; Liu, NanNan; Wei, Guangyi; Liu, Shan; Zhang, Sen; Jiang, Nan; Yang, Haiguang; Du, Guanhua*Pharmacological Research, 2022, 175: 105989.被引 16
  • Tongxinluo Enhances Neurogenesis and Angiogenesis in Peri-Infarct Area and Subventricular Zone and Promotes Functional Recovery after Focal Cerebral Ischemic Infarction in Hypertensive Rats
    Chen Li; Wang Xiaoting; Zhang Jian; Dang Chao; Liu Gang; Liang Zhijian; Huang Gelun; Zhao Weijia; Zeng Jinsheng*Evidence-based Complementary and Alternative Medicine, 2016, 8549590.
  • Hydroxysafflor Yellow A and Tenuigenin Exhibit Neuroprotection Effects Against Focal Cerebral Ischemia Via Differential Regulation of JAK2/STAT3 and SOCS3 Signaling Interaction
    Yu, Lu; Zhang, Cheng; Gu, Lingling; Chen, Hong; Huo, Yan; Wang, Shuyan; Tao, Jie; Xu, Chuan; Zhang, Qiujuan*; Ma, Mingliang*; Zhang, Jun*Molecular Neurobiology, 2024.
查看全部 →

发表信息

论文状态
公开发表
期刊
Acta Pharmacologica Sinica
发表日期
2022-09
卷期
第 43 卷, 第 9 期
页码
2212-2225
DOI
10.1038/s41401-021-00844-9
语言
ENGLISH
期刊收录
CSCD-C.CAST-P
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82004071]; Beijing Municipal Natural Science Foundation [7182113]; Fundamental Research Funds for the Central Universities [3332020038]

作者

  • Z

    Zhang, Sen (第一作者)

    chinese acad med sci · peking union med coll

  • K

    Kong, De-Wen

    chinese acad med sci · peking union med coll

查看全部 11 位作者收起作者
  • M

    Ma, Guo-Dong

    chinese acad med sci · peking union med coll

  • L

    Liu, Cheng-di

    chinese acad med sci · peking union med coll

  • Y

    Yang, Yu-Jiao

    shenyang pharmaceut univ · chinese acad med sci · peking union med coll

  • L

    Liu, Shan

    guangdong pharmaceut univ · chinese acad med sci · peking union med coll

  • J

    Jiang, Nan

    henan univ · chinese acad med sci · peking union med coll

  • P

    Pan, Zi-Rong

    chinese acad med sci · peking union med coll

  • Z

    Zhang, Wen

    chinese acad med sci · peking union med coll

  • K

    Kong, Ling-Lei (通讯)

    chinese acad med sci · peking union med coll

  • D

    Du, Guan-Hua (通讯)

    chinese acad med sci · peking union med coll

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417